The contribution of an arteriovenous access for hemodialysis to left ventricular hypertrophy

American Journal of Kidney Diseases - Tập 40 - Trang 745-752 - 2002
Yaacov Ori1, Asher Korzets1, Menachem Katz1, Arie Erman1, Talia Weinstein1, Tsipora Malachi1, Uzi Gafter1
1Departments of Nephrology and Cardiology, Rabin Medical Center, Golda Campus, Hasharon; Institute of Hypertension and Kidney Disease, Rabin Medical Center, Beilinson Campus, Petah-Tikva; and Sackler Medical School, Tel-Aviv, Israel

Tài liệu tham khảo

Munclinger, 1987, Effects of arteriovenous fistula creation and maturation on rest hemodynamics in patients with end-stage renal disease, Nephron, 46, 105, 10.1159/000184321

London, 1987, Uremic cardiomyopathy: An inadequate left ventricular hypertrophy, Kidney Int, 31, 973, 10.1038/ki.1987.94

Anderson, 1978, Cardiac failure and upper extremity arteriovenous dialysis fistulas, Arch Intern Med, 136, 292, 10.1001/archinte.1976.03630030026006

Ahearn, 1972, Heart failure as a complication of hemodialysis arteriovenous fistula, Ann Intern Med, 77, 201, 10.7326/0003-4819-77-2-201

Ori, 1996, Haemodialysis arteriovenous access—A prospective haemodynamic evaluation, Nephrol Dial Transplant, 11, S94, 10.1093/oxfordjournals.ndt.a027073

Foley, 1995, The prognostic importance of left ventricular geometry in uremic cardiomyopathy, J Am Soc Nephrol, 5, 2024, 10.1681/ASN.V5122024

London, 1998, Heterogeneity of left ventricular hypertrophy—Does it have clinical implications?, Nephrol Dial Transplant, 13, 17, 10.1093/ndt/13.1.17

Schiller, 1989, Recommendations for quantitation of the left ventricle by two-dimensional echocardiography, J Am Soc Echocardiogr, 2, 358, 10.1016/S0894-7317(89)80014-8

Devereux, 1977, Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method, Circulation, 55, 613, 10.1161/01.CIR.55.4.613

de Simone, 1992, Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and impact of overweight, J Am Coll Cardiol, 20, 1251, 10.1016/0735-1097(92)90385-Z

Wachtell, 2000, Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population, Hypertension, 35, 6, 10.1161/01.HYP.35.1.6

Zoccali, 2001, Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis, J Am Soc Nephrol, 12, 2768, 10.1681/ASN.V12122768

McLenachan, 1987, Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy, N Engl J Med, 317, 787, 10.1056/NEJM198709243171302

Ruffmann, 1990, Doppler echocardiographic findings in dialysed patients, Nephrol Dial Transplant, 5, 426, 10.1093/ndt/5.6.426

Amann, 1998, Myocyte/capillary mismatch in the heart of uremic patients, J Am Soc Nephrol, 9, 1018, 10.1681/ASN.V961018

Abassi, 2001, Temporal changes in natriuretic and antinatriuretic systems after closure of a large arteriovenous fistula, Cardiovasc Res, 51, 567, 10.1016/S0008-6363(01)00245-0

Ruzicka, 1995, Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats, Circulation, 92, 3568, 10.1161/01.CIR.92.12.3568

Leskinen, 1997, Combined inhibition of endothelin and angiotensin II receptors blocks volume load-induced cardiac hormone release, Circ Res, 80, 114, 10.1161/01.RES.80.1.114

Ishiye, 1995, Effects of losartan, an angiotensin II antagonist, on the development of cardiac hypertrophy due to volume overload, Biol Pharm Bull, 18, 700, 10.1248/bpb.18.700

Fujisaki, 1995, Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression, J Clin Invest, 96, 1059, 10.1172/JCI118092

Demuth, 1998, Endothelin and cardiovascular remodeling in end-stage renal disease, Nephrol Dial Transplant, 13, 375, 10.1093/oxfordjournals.ndt.a027833

Silberberg, 1990, Regression of left ventricular hypertrophy in dialysed patients following correction of anemia with recombinant human erythropoietin, Can J Cardiol, 6, 1

Foley, 2000, Effects of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy, Kidney Int, 58, 1325, 10.1046/j.1523-1755.2000.00289.x

Amann, 1999, Treatment of cardiovascular changes in renal failure—ACE inhibition, endothelin receptor blockade or a combination of both strategies?, Nephrol Dial Transplant, 14, S43, 10.1093/ndt/14.suppl_4.43

National Kidney Foundation, 2001, K/DOQI Clinical Practice Guidelines for Vascular Access, 2000, Am J Kidney Dis, 37, S137